Location: Home
  • search
  • go
  • Relate News
  • 7/17/2018Medicines Containing Huahai's Valsartan API Recalled in EU and U.S.
  • 7/17/2018Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial
  • 7/17/2018CDE Publicizes Batch 30 of Drug Applications To Be Granted Priority Re...
  • 7/17/2018State Council Revamps Healthcare Reform Leading Group
  • 7/17/2018Ascentage Pharma Raises $150 Million in Series C Financing
  • 7/17/2018China Embraces Another Vaccine Scandal
  • 7/16/2018Shanghai AIC Officially Terminates Antimonopoly Investigation of the C...
  • 7/16/2018Healthcare Industry Associations Sign New Framework for Business Ethic...
  • 7/13/2018Recent Executive Moves
  • 7/13/2018CNDA Solicits Comments on GMP for Clinical Trial Drugs
  • 7/13/2018SMIA Mulls Tender for Anticancers as It Plans New Mechanism for Updati...
  • 7/13/2018NHC Reports on Growing Sector of Private Healthcare Providers in China
  • 7/12/2018Merck and Xian Janssen to Co-launch Type 2 Diabetes Drug in China
  • 7/12/2018Sirona Biochem Announces CNDA Approval of SGLT2 Inhibitor for Phase I ...
  • 7/12/2018CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Approval in China
  • 7/11/2018Shanghai Unveils New Open Policy Measures, Benefiting Pharma/MedTech I...
  • 7/11/2018CDE Solicits Comments on Technical Requirements for Topical Dermatolog...
  • 7/10/2018Ping An Reportedly to Make Rival Offer for China Biologic
  • 7/10/2018Transgene Swaps JV Ownership for Stake in Tasly Biopharma
  • 7/10/2018CNDA Issues Technical Guidelines for Acceptance of Foreign Drug Clinic...
  • 7/10/2018Updated - NHC Issues Drug Prescription Review Guidelines of Medical In...
  • 7/10/2018iBio Establishes Strategic Commercial Relationship with CC-Pharming
  • 7/10/2018China Agrees to Slash Import Duties on Indian Medicines
  • 7/10/2018U.S. FDA and CNDA Officials Meet to Exchange Anticancer Regulatory Exp...
  • 7/10/2018Tocagen Closes Licensing Deal with ApolloBio for Immunotherapy Toca 51...
  • 7/10/2018China's Biopharma Rise: Opportunities and Threats
  • 7/6/2018CDE Seeks Comments on Draft ICH Guideline Q3D(R1): Elemental Impuritie...
  • 7/6/2018Adlai Nortye Biopharma $53M in Series B Round
  • 7/6/2018BIO's China Summit Highlights Trends in BioPharma Market
  • 7/6/2018Chinese Film Defending Smuggled Indian Anticancers Triggers Intensive ...
  • Page:321/778 Total number of articles:23339: [First][<<] [319] [320] [321] [322] [323] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group